ArticleCureus2025
Diagnostic Utility of the Ocular Surface Test for Psoriasis-Associated Conjunctivitis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psoriasis-associated conjunctivitis, a rare eye complication in patients with psoriasis, is not always accurately diagnosed. The symptoms may become prolonged, making treatment challenging. We report the case of a patient with psoriasis-associated conjunctivitis for whom we identified biomarkers for psoriasis in an ocular surface test. A 64-year-old female patient presented with refractory conjunctivitis that recurred despite treatment with a combination of steroids and antimicrobial eye drops and dry eye treatment. She had a long history of symptoms of psoriasis without treatment. Slit-lamp examination at the initial visit to our hospital revealed severe conjunctival hyperemia without conjunctival papillae or follicles and punctate superficial keratitis in the inferior area of the cornea. We initiated treatment with betamethasone ophthalmic solution and tacrolimus ointment for eyelid application, and her conjunctivitis improved one week following the initial visit. An ocular surface test was performed to measure the levels of cytokine and chemokine mRNA expression and profile of inflammasome-associated factors on the ocular surface. When comparing the specimens obtained at the initial visit and those taken one week later, interleukin (IL)-17A and IL-22 were expressed in the right eye, and IL-1β, prostaglandin-endoperoxide synthase 2 (PTGS2/COX-2), NOD-like receptor family CARD domain-containing protein 4 (NLRC4), Familial Mediterranean Fever (MEFV) gene, and caspase 5 (CASP5) decreased by more than six-fold. Changes in biomarkers associated with psoriasis pathology can be observed in ocular surface tests of patients with psoriasis-associated conjunctivitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.